{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T02:11:11Z","timestamp":1785636671643,"version":"3.56.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/coc.0b013e3181c4c7a8","type":"journal-article","created":{"date-parts":[[2010,3,27]],"date-time":"2010-03-27T09:24:09Z","timestamp":1269681849000},"page":"115-119","source":"Crossref","is-referenced-by-count":28,"title":["Phase II Study of Radiation Therapy Combined With Weekly Low-Dose Gemcitabine for Locally Advanced, Unresectable Pancreatic Cancer"],"prefix":"10.1097","volume":"34","author":[{"given":"Keiko","family":"Shibuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuo","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihide","family":"Mitsumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","article-title":"Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil.","volume":"48","author":"Moertel","year":"1981","journal-title":"Cancer"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0360-3016(01)02740-7","article-title":"Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?","volume":"52","author":"Crane","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.bjc.6602001","article-title":"Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.","volume":"91","author":"Okusaka","year":"2004","journal-title":"Br J Cancer"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/030089160609200603","article-title":"Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer.","volume":"92","author":"Kurt","year":"2006","journal-title":"Tumori"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1385\/IJGC:34:2-3:107","article-title":"Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.","volume":"34","author":"Blackstock","year":"2003","journal-title":"Int J Gastrointest Cancer"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jso.10159","article-title":"Phase II study of gemcitabine with radiation therapy in patients with localized, unresectable pancreatic cancer.","volume":"81","author":"Epelbaum","year":"2002","journal-title":"J Surg Oncol"},{"key":"R8-2-20210128","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ijrobp.2006.10.015","article-title":"Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemicitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.","volume":"67","author":"Brade","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-2-20210128","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2001.19.22.4202","article-title":"Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.","volume":"19","author":"McGinn","year":"20001","journal-title":"J Clin Oncol"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000090030","article-title":"Chemoradiotherapy in patients with pancreatic carcinoma: phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine.","volume":"6","author":"Oya","year":"2006","journal-title":"Pancreatology"},{"key":"R11-2-20210128","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(69)92326-5","article-title":"Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.","volume":"2","author":"Moertel","year":"1969","journal-title":"Lancet"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnci\/80.10.751","article-title":"Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone.","volume":"80","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"R13-2-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.1985.3.3.373","article-title":"Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil\u2013an Eastern Cooperative Oncology Group study.","volume":"3","author":"Klaassen","year":"1985","journal-title":"J Clin Oncol"},{"key":"R14-2-20210128","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2006.09.2551","article-title":"Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer.","volume":"25","author":"Sultana","year":"2007","journal-title":"J Clin Oncol"},{"key":"R15-2-20210128","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"R16-2-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1470-2045(05)70175-3","article-title":"Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial.","volume":"6","author":"Reni","year":"2007","journal-title":"Lancet Oncol"},{"key":"R17-2-20210128","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00280-007-0514-8","article-title":"A late phase II study of S-1 for metastatic pancreatic cancer.","volume":"61","author":"Okusaka","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"R18-2-20210128","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/annonc\/mdn281","article-title":"Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000\u201301 FFCD\/SFRO study.","volume":"19","author":"Chauffert","year":"2008","journal-title":"Ann Oncol"},{"key":"R19-2-20210128","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1200\/JCO.2005.03.0361","article-title":"; Eastern Cooperative Oncology Group. A randomized phase III study of gemcitabine with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201.","volume":"23","author":"Loehrer","year":"2008","journal-title":"J Clin Oncol"},{"key":"R20-2-20210128","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/1097-0142(20010401)91:7<1384::AID-CNCR1142>3.0.CO;2-4","article-title":"Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.","volume":"91","author":"Okusaka","year":"2008","journal-title":"Cancer"},{"key":"R21-2-20210128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1054\/bjoc.1999.0884","article-title":"Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.","volume":"82","author":"Kornek","year":"2008","journal-title":"Br J Cancer"},{"key":"R22-2-20210128","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000421-199906000-00021","article-title":"Combined chemoradiotherapy for unresectable pancreatic cancer.","volume":"22","author":"Martin","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"R23-2-20210128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0360-3016(00)01388-2","article-title":"Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.","volume":"49","author":"Kornek","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000421-201104000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:51:58Z","timestamp":1618033918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201104000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e3181c4c7a8","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}